SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-053321
Filing Date
2020-11-12
Accepted
2020-11-12 08:18:18
Documents
44
Period of Report
2020-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K INVESTOR PRESENTATION atrs-8k_20201112.htm   iXBRL 8-K 40972
2 EX-99.1 INVESTOR PRESENTATION atrs-ex991_6.htm EX-99.1 26370
3 GRAPHIC gevb2hi1hysw000026.jpg GRAPHIC 134904
4 GRAPHIC gevb2hi1hysw000023.jpg GRAPHIC 166439
5 GRAPHIC gevb2hi1hysw000011.jpg GRAPHIC 140252
6 GRAPHIC gevb2hi1hysw000019.jpg GRAPHIC 167610
7 GRAPHIC gevb2hi1hysw000010.jpg GRAPHIC 167146
8 GRAPHIC gevb2hi1hysw000001.jpg GRAPHIC 124520
9 GRAPHIC gevb2hi1hysw000012.jpg GRAPHIC 101941
10 GRAPHIC gevb2hi1hysw000025.jpg GRAPHIC 138050
11 GRAPHIC gevb2hi1hysw000006.jpg GRAPHIC 114091
12 GRAPHIC gevb2hi1hysw000009.jpg GRAPHIC 154801
13 GRAPHIC gevb2hi1hysw000027.jpg GRAPHIC 117780
14 GRAPHIC gevb2hi1hysw000030.jpg GRAPHIC 174674
15 GRAPHIC gevb2hi1hysw000007.jpg GRAPHIC 104314
16 GRAPHIC gevb2hi1hysw000017.jpg GRAPHIC 94449
17 GRAPHIC gevb2hi1hysw000031.jpg GRAPHIC 199516
18 GRAPHIC gevb2hi1hysw000014.jpg GRAPHIC 212517
19 GRAPHIC gevb2hi1hysw000021.jpg GRAPHIC 174845
20 GRAPHIC gevb2hi1hysw000004.jpg GRAPHIC 233402
21 GRAPHIC gevb2hi1hysw000003.jpg GRAPHIC 193580
22 GRAPHIC gevb2hi1hysw000022.jpg GRAPHIC 135638
23 GRAPHIC gevb2hi1hysw000002.jpg GRAPHIC 411296
24 GRAPHIC gevb2hi1hysw000008.jpg GRAPHIC 167912
25 GRAPHIC gevb2hi1hysw000013.jpg GRAPHIC 202891
26 GRAPHIC gevb2hi1hysw000015.jpg GRAPHIC 173998
27 GRAPHIC gevb2hi1hysw000016.jpg GRAPHIC 197489
28 GRAPHIC gevb2hi1hysw000005.jpg GRAPHIC 134508
29 GRAPHIC gevb2hi1hysw000029.jpg GRAPHIC 133761
30 GRAPHIC gevb2hi1hysw000020.jpg GRAPHIC 159195
31 GRAPHIC gevb2hi1hysw000028.jpg GRAPHIC 63890
32 GRAPHIC gevb2hi1hysw000024.jpg GRAPHIC 165768
33 GRAPHIC gevb2hi1hysw000018.jpg GRAPHIC 146659
  Complete submission text file 0001564590-20-053321.txt   7107499

Data Files

Seq Description Document Type Size
34 XBRL TAXONOMY EXTENSION SCHEMA atrs-20201112.xsd EX-101.SCH 5796
35 XBRL TAXONOMY EXTENSION LABEL LINKBASE atrs-20201112_lab.xml EX-101.LAB 19478
36 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atrs-20201112_pre.xml EX-101.PRE 11645
37 EXTRACTED XBRL INSTANCE DOCUMENT atrs-8k_20201112_htm.xml XML 3549
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 201303541
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences